← Back to Search

Greek Yogurt Consumption for Bone Development in Athletes

N/A
Recruiting
Led By Panagiota Klentrou, PhD
Research Sponsored by Brock University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up completion of intervention period (week 24)
Awards & highlights

Study Summary

This trial will look at whether combining physical activity and dairy consumption can help young athletes maximize their peak bone mass and improve their health.

Who is the study for?
This trial is for young competitive athletes who are looking to improve their bone health. Participants should be actively engaged in sports and not have any allergies to dairy, lactose intolerance, or injuries that prevent them from practicing.Check my eligibility
What is being tested?
The study is testing if eating more Greek yogurt can help with bone development and reduce inflammation in youth and young adult athletes. It compares the effects of Greek yogurt consumption to whey protein supplementation during athletic training.See study design
What are the potential side effects?
Since Greek yogurt is a common food item, side effects might include typical dairy digestion issues like bloating or stomach discomfort, especially for those unaccustomed to higher dairy intake.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~completion of intervention period (week 24)
This trial's timeline: 3 weeks for screening, Varies for treatment, and completion of intervention period (week 24) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amino-terminal propeptide of type I collagen (P1NP)
C-telopeptides of type I collagen (CTX)
Interleukin-10 (IL10)
+7 more
Secondary outcome measures
Body fat percentage
Body mass
Bone Properties
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Whey protein intervention group (WP)Experimental Treatment1 Intervention
Participants in the WP group will follow a similar consumption schedule but will be instructed by the RD to consume two servings/day (preferably morning and night) each of 2/3 of a scoop of commercially available WP powder (flavoured, ~29 g, 120 calories, 19 g protein, 112.5 g calcium; e.g., PURE Whey Protein, Walmart) for a total of 16 weeks. The WP scoop will be dissolved in water (e.g., 1 g of WP isolate to 10 mL of water, as recommended by the manufacturer). This protein dose is similar to the previous dose in young swimmers and comparable to other studies in adults. Athletes will be provided with appropriately marked scoops (corresponding to 2/3 of the manufacturer scoop) to measure their single servings. Each athlete will receive two large containers (2 x 907 g = 1814 g per week) at the beginning of each week, which will be enough to cover the two daily servings of 29 g (i.e., 58 g/day).
Group II: Greek yogurt intervention group (GY)Experimental Treatment1 Intervention
Participants in the GY group will be instructed by a registered dietician to consume 2 servings/day (preferably morning and night) of 175 g GY (0% MF, flavoured, 130 calories, 17 g protein, 225 g calcium; e.g., OIKOS High Protein GY) for a total of 16 weeks. For their convenience, the athletes will be provided with appropriate scoops to measure out 175 g of GY per serving of the larger 650 g commercially available, pre-packaged containers. Although it is recommended to consume the two servings morning and night, to increase ecological validity and strengthen the feasibility of the intervention, the timing of the servings will be flexible to facilitate the training and competition routines. For the same reasons, the athletes will be able to choose the flavour of their GY.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Whey protein
2011
Completed Phase 4
~1180
Greek yogurt
2011
N/A
~40

Find a Location

Who is running the clinical trial?

Brock UniversityLead Sponsor
38 Previous Clinical Trials
2,039 Total Patients Enrolled
5 Trials studying Inflammation
118 Patients Enrolled for Inflammation
York UniversityOTHER
58 Previous Clinical Trials
17,436 Total Patients Enrolled
3 Trials studying Inflammation
70 Patients Enrolled for Inflammation
Panagiota Klentrou, PhDPrincipal InvestigatorBrock University
3 Previous Clinical Trials
102 Total Patients Enrolled
1 Trials studying Inflammation
60 Patients Enrolled for Inflammation

Media Library

Whey protein intervention group (WP) Clinical Trial Eligibility Overview. Trial Name: NCT05922462 — N/A
Inflammation Research Study Groups: Whey protein intervention group (WP), Greek yogurt intervention group (GY)
Inflammation Clinical Trial 2023: Whey protein intervention group (WP) Highlights & Side Effects. Trial Name: NCT05922462 — N/A
Whey protein intervention group (WP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05922462 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I be eligible to participate in this clinical trial?

"To be considered, potential participants must possess a measurable degree of inflammation and have not yet reached their 23rd birthday. This trial is expecting to recruit 40 individuals in total."

Answered by AI

Are there any remaining slots for participants in this trail?

"Based on the information available, this medical study is no longer recruiting. The trial was initially posted 9th of September 2023 and last updated 25th June 2023; 357 other trials are currently looking for participants."

Answered by AI

Are adults over the age of 30 being accepted into this research trial?

"This research initiative is open to participants aged between 15 and 22 years old."

Answered by AI

What potential results are researchers expecting from this medical exploration?

"This study, which will last for 24 weeks, involves assessing the Amino-terminal propeptide of type I collagen (P1NP). The secondary objectives are centred around testosterone and estrogen levels in male/female athletes respectively as well as body mass determined through Bioelectrical Impedance."

Answered by AI
~27 spots leftby Jun 2025